SEI Investments
CRBU icon

SEI Investments’s Caribou Biosciences CRBU Stock Holding History

SEI Investments’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Buy
41,939
+10,931
+35% +$21.6K ﹤0.01% 3212
2026
Q1 		$58.9K Buy
+31,008
New +$53.2K ﹤0.01% 3162
2025
Q2 		– Sell
-64,364
Closed -$58.8K – 2812
2025
Q1 		$58.8K Hold
64,364
– – ﹤0.01% 2668
2024
Q4 		$102K Buy
+64,364
New +$129K ﹤0.01% 2579

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SEI Investments's CRBU Position: Q2 2026 in Review

SEI Investments increased its Caribou Biosciences (CRBU) stake by 35% in Q2 2026, buying an estimated $21.6K and bringing the position to 41,939 shares worth $73.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

SEI Investments first reported a position in CRBU in Q4 2024 and has held it in 4 quarters since. The position peaked at $102K in Q4 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • SEI Investments held 41,939 shares of Caribou Biosciences worth $73.8K as of Q2 2026.
  • SEI Investments bought 10,931 Caribou Biosciences shares in Q2 2026, an estimated $21.6K.
  • Caribou Biosciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3212 holding.
  • SEI Investments first reported a position in Caribou Biosciences in Q4 2024 and has held it in 4 quarters since.
  • SEI Investments's Caribou Biosciences position peaked at $102K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.